AI brief of an SEC Form 8-K · Aptiv (APTV)

Aptiv unit assumes senior and subordinated notes in intra-group merger

Neutral Impact 2 of 5 restructuring Written later

On December 19, 2024, Aptiv Swiss Holdings merged with Aptiv Irish Holdings, with Aptiv Swiss Holdings surviving, both wholly owned subsidiaries of Aptiv PLC. As successor issuer, Aptiv Swiss Holdings assumed the obligations on 11 series of senior notes and $500 million of 6.875% junior subordinated notes due 2054. The filing describes an internal reorganization and does not report any change to Aptiv PLC's financial results.

Key points

  • Merger agreement dated November 4, 2024; Aptiv Irish Holdings shareholders approved the merger at an extraordinary general meeting on December 2, 2024.
  • Aptiv Swiss Holdings assumed 11 series of senior notes, including €500 million 1.60% notes due 2028 and $1,500 million 3.10% notes due 2051.
  • Aptiv Swiss Holdings assumed the $500 million 6.875% Fixed-to-Fixed Reset Rate Junior Subordinated Notes due 2054 under a subordinated indenture dated September 13, 2024.
  • Supplemental indentures are filed as Exhibits 4.1 and 4.2 with the Trustee, Wilmington Trust, National Association.

The filing

CompanyAptiv (APTV)
Form8-K, current report
Filed with the SECDec 19, 2024, 4:15 PM ET
Accession number0001193125-24-282021

Items reported: 1.01 Material Definitive Agreement

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:17 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on December 19, 2024.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.